2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 131.666 | 126.762 | 122.928 | 133.503 | 140.482 | 135.391 | 142.933 | 122.565 | 138.065 | 107.301 |
Total Income - EUR | 131.670 | 135.897 | 122.944 | 133.551 | 140.776 | 136.896 | 142.937 | 122.569 | 138.661 | 109.157 |
Total Expenses - EUR | 124.842 | 134.502 | 124.659 | 131.243 | 136.384 | 126.681 | 131.615 | 112.929 | 135.359 | 112.450 |
Gross Profit/Loss - EUR | 6.828 | 1.394 | -1.715 | 2.308 | 4.392 | 10.215 | 11.322 | 9.640 | 3.302 | -3.292 |
Net Profit/Loss - EUR | 5.360 | 57 | -2.211 | 28 | 2.984 | 8.844 | 10.063 | 8.536 | 1.915 | -3.292 |
Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 |
Check the financial reports for the company - Viafarm Doi Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 1.621 | 29.696 | 23.762 | 17.203 | 311 | 115 | 51 | 0 | 0 | 0 |
Current Assets | 42.205 | 38.010 | 31.276 | 32.609 | 39.634 | 44.529 | 41.238 | 40.805 | 36.541 | 25.998 |
Inventories | 15.341 | 14.604 | 12.946 | 14.071 | 13.080 | 13.963 | 13.354 | 24.130 | 14.789 | 14.647 |
Receivables | 15.055 | 16.138 | 2.960 | 11.396 | 14.153 | 10.168 | 13.559 | 11.228 | 12.054 | 3.966 |
Cash | 11.810 | 7.268 | 15.371 | 7.141 | 12.401 | 20.398 | 14.325 | 5.447 | 9.698 | 7.384 |
Shareholders Funds | 6.063 | 766 | -1.453 | -1.400 | 1.610 | 8.894 | 10.113 | 8.584 | 1.963 | -3.200 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 38.008 | 67.267 | 57.082 | 51.697 | 38.810 | 36.122 | 31.583 | 32.269 | 34.779 | 29.198 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4773 - 4773" | |||||||||
CAEN Financial Year |
4773
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Viafarm Doi Srl